SARS-CoV-2 anti-spike antibody titres after vaccination with BNT162b2 in naive and previously infected individuals

被引：23

作者：

Lombardi, Andrea ^{[1
,2
]}

Consonni, Dario ^{[3
]}

Oggioni, Massimo ^{[4
]}

Bono, Patrizia ^{[4
]}

Renteria, Sara U. ^{[4
]}

Piatti, Alessandra ^{[5
]}

Pesatori, Angela C. ^{[3
,6
]}

Castaldi, Silvana ^{[7
,8
]}

Muscatello, Antonio ^{[1
]}

Riboldi, Luciano ^{[9
]}

Ceriotti, Ferruccio ^{[4
]}

Bandera, Alessandra ^{[1
,2
,10
]}

Gori, Andrea ^{[1
,2
,10
]}

机构：

[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Infect Dis Unit, Via Francesco Sforza 35, I-20122 Milan, Italy

[2] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy

[4] Fdn IRCCS Ca Granda Osped Maggiore, Clin Lab, Milan, Italy

[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Med Direct, Milan, Italy

[6] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy

[7] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy

[8] Univ Milan, Qual & Internal Audit Privacy Unit, Milan, Italy

[9] Fdn IRCCS Ca Granda Osped MaggiorePoliclin, Occupat Hlth Unit, Milan, Italy

[10] Univ Milan, Ctr Multidisciplinary Res Hlth Sci MACH, Milan, Italy

来源：

JOURNAL OF INFECTION AND PUBLIC HEALTH | 2021年 / 14卷 / 08期

关键词：

COVID-19; Vaccination; Healthcare workers; BNT162b2;

D O I：

10.1016/j.jiph.2021.07.005

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

Great expectations are placed in vaccines against COVID-19 to control the pandemic. We reviewed the antibody titres in a cohort of healthcare workers (HCWs) vaccinated with BNT162b2 to assess the influence of a previous infection on them. We stratified the results according to the individual history of nasopharyngeal swab (NPS) and symptoms. Among 3475 HCWs the highest titres were recorded among those infected more than 6 months before vaccination, independently of symptoms, followed by those infected less than 6 months before vaccination, especially in those with symptoms, and by uninfected HCWs. Vaccination with BNT162b2 can boost immunity acquired through infection, particularly in those infected more than 6 months before vaccination. (c) 2021 The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).

引用

页码：1120 / 1122

页数：3

共 50 条

[1] Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Joseph E. Ebinger
Justyna Fert-Bober
Ignat Printsev
Min Wu
Nancy Sun
John C. Prostko
Edwin C. Frias
James L. Stewart
Jennifer E. Van Eyk
Jonathan G. Braun
Susan Cheng
Kimia Sobhani
Nature Medicine, 2021, 27 : 981 - 984
[2] Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2
Ebinger, Joseph E.
Fert-Bober, Justyna
Printsev, Ignat
Wu, Min
Sun, Nancy
Prostko, John C.
Frias, Edwin C.
Stewart, James L.
Van Eyk, Jennifer E.
Braun, Jonathan G.
Cheng, Susan
Sobhani, Kimia
NATURE MEDICINE, 2021, 27 (06) : 981 - +
[3] SARS-CoV-2 Antibody Responses in Infection-Naive or Previously Infected Individuals After 1 and 2 Doses of the BNT162b2 Vaccine
Anderson, Mark
Stec, Michael
Rewane, Ayesan
Landay, Alan
Cloherty, Gavin
Moy, James
JAMA NETWORK OPEN, 2021, 4 (08)
[4] Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations
Efrati, Shai
Catalogna, Merav
Abu Hamad, Ramzia
Hadanny, Amir
Bar-Chaim, Adina
Benveniste-Levkovitz, Patricia
Levtzion-korach, Osnat
SCIENTIFIC REPORTS, 2021, 11 (01)
[5] Safety and humoral responses to BNT162b2 mRNA vaccination of SARS-CoV-2 previously infected and naive populations
Shai Efrati
Merav Catalogna
Ramzia Abu Hamad
Amir Hadanny
Adina Bar-Chaim
Patricia Benveniste-Levkovitz
Osnat Levtzion-korach
Scientific Reports, 11
[6] Induction of SARS-CoV-2 neutralizing antibodies by CoronaVac and BNT162b2 vaccines in naive and previously infected individuals
Muena, Nicolas A.
Garcia-Salum, Tamara
Pardo-Roa, Catalina
Jose Avendano, Maria
Serrano, Eileen F.
Levican, Jorge
Almonacid, Leonardo, I
Valenzuela, Gonzalo
Poblete, Estefany
Strohmeier, Shirin
Salinas, Erick
Munoz, Andres
Haslwanter, Denise
Dieterle, Maria Eugenia
Jangra, Rohit K.
Chandran, Kartik
Gonzalez, Claudia
Riquelme, Arnoldo
Krammer, Florian
Tischler, Nicole D.
Medina, Rafael A.
EBIOMEDICINE, 2022, 78
[7] Spike Antibody Titers Evaluation after a 2-Dose Regimen of BNT162b2 Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2
Kayukawa, Satoshi
Nanya, Kengo
Morita, Makoto
Ina, Kenji
Ota, Yoshihiro
Hasegawa, Shinji
MICROBIOLOGY SPECTRUM, 2021, 9 (03):
[8] SARS-CoV-2 infection shortly after BNT162b2 vaccination results in high anti-spike antibody levels in nursing home residents and staff
Urlaub, Doris
Wolfsdorff, Natalie
Durak, Deniz
Renken, Frank
Watzl, Carsten
IMMUNITY INFLAMMATION AND DISEASE, 2021, 9 (04) : 1702 - 1706
[9] Antibody Response after BNT162b2 Vaccination in Healthcare Workers Previously Exposed and Not Exposed to SARS-CoV-2
Salvaggio, Marcello
Fusina, Federica
Albani, Filippo
Salvaggio, Maurizio
Beschi, Rasula
Ferrari, Emanuela
Costa, Alberto
Agnoletti, Laura
Facchi, Emanuela
Natalini, Giuseppe
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (18)
[10] Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals
Manisty, Charlotte
Otter, Ashley D.
Treibel, Thomas A.
McKnight, Aine
Altmann, Daniel M.
Brooks, Timothy
Noursadeghi, Mahdad
Boyton, Rosemary J.
Semper, Amanda
Moon, James C.
LANCET, 2021, 397 (10279): : 1057 - 1058

← 1 2 3 4 5 →